nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PPARG—stomach cancer	0.279	0.727	CbGaD
Nateglinide—ALB—stomach cancer	0.105	0.273	CbGaD
Nateglinide—UGT1A9—Irinotecan—stomach cancer	0.0668	0.155	CbGbCtD
Nateglinide—SLC16A1—Methotrexate—stomach cancer	0.0616	0.143	CbGbCtD
Nateglinide—ABCC4—Fluorouracil—stomach cancer	0.0537	0.124	CbGbCtD
Nateglinide—ABCC4—Methotrexate—stomach cancer	0.0296	0.0686	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0222	0.0515	CbGbCtD
Nateglinide—CYP3A7—Irinotecan—stomach cancer	0.0222	0.0515	CbGbCtD
Nateglinide—ALB—Irinotecan—stomach cancer	0.0207	0.0481	CbGbCtD
Nateglinide—ALB—Fluorouracil—stomach cancer	0.0199	0.0461	CbGbCtD
Nateglinide—CYP2C9—Capecitabine—stomach cancer	0.0181	0.0419	CbGbCtD
Nateglinide—CYP3A5—Irinotecan—stomach cancer	0.0167	0.0386	CbGbCtD
Nateglinide—CYP3A7—Docetaxel—stomach cancer	0.0163	0.0377	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0163	0.0377	CbGbCtD
Nateglinide—SLC22A6—Methotrexate—stomach cancer	0.0129	0.0299	CbGbCtD
Nateglinide—CYP3A5—Docetaxel—stomach cancer	0.0122	0.0283	CbGbCtD
Nateglinide—ALB—Methotrexate—stomach cancer	0.011	0.0254	CbGbCtD
Nateglinide—CYP2C9—Fluorouracil—stomach cancer	0.0107	0.0249	CbGbCtD
Nateglinide—CYP3A4—Irinotecan—stomach cancer	0.0065	0.0151	CbGbCtD
Nateglinide—ORM1—bile—stomach cancer	0.00597	0.112	CbGeAlD
Nateglinide—CYP2D6—Doxorubicin—stomach cancer	0.00558	0.0129	CbGbCtD
Nateglinide—CYP3A4—Docetaxel—stomach cancer	0.00476	0.011	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—stomach cancer	0.00355	0.00823	CbGbCtD
Nateglinide—PPARG—Topotecan—Irinotecan—stomach cancer	0.00274	1	CbGdCrCtD
Nateglinide—ORM1—gall bladder—stomach cancer	0.00166	0.0312	CbGeAlD
Nateglinide—PPARG—blood vessel—stomach cancer	0.00165	0.031	CbGeAlD
Nateglinide—ALB—gall bladder—stomach cancer	0.00145	0.0273	CbGeAlD
Nateglinide—KCNJ11—hematopoietic system—stomach cancer	0.00125	0.0235	CbGeAlD
Nateglinide—UGT1A9—digestive system—stomach cancer	0.00124	0.0233	CbGeAlD
Nateglinide—Hepatitis cholestatic—Capecitabine—stomach cancer	0.00118	0.0261	CcSEcCtD
Nateglinide—Gastrointestinal symptom NOS—Fluorouracil—stomach cancer	0.00116	0.0256	CcSEcCtD
Nateglinide—SLC16A1—hematopoietic system—stomach cancer	0.00104	0.0197	CbGeAlD
Nateglinide—UGT1A9—endocrine gland—stomach cancer	0.00102	0.0193	CbGeAlD
Nateglinide—KCNJ11—pancreas—stomach cancer	0.00102	0.0191	CbGeAlD
Nateglinide—ABCC8—smooth muscle tissue—stomach cancer	0.00101	0.019	CbGeAlD
Nateglinide—SLC15A1—epithelium—stomach cancer	0.001	0.0189	CbGeAlD
Nateglinide—SLC16A1—epithelium—stomach cancer	0.000955	0.018	CbGeAlD
Nateglinide—ORM1—hematopoietic system—stomach cancer	0.000938	0.0176	CbGeAlD
Nateglinide—ABCC8—pancreas—stomach cancer	0.000935	0.0176	CbGeAlD
Nateglinide—UGT1A9—liver—stomach cancer	0.000923	0.0174	CbGeAlD
Nateglinide—PTGS1—blood vessel—stomach cancer	0.00088	0.0166	CbGeAlD
Nateglinide—KCNJ11—lymphoid tissue—stomach cancer	0.000878	0.0165	CbGeAlD
Nateglinide—PPARG—hematopoietic system—stomach cancer	0.000877	0.0165	CbGeAlD
Nateglinide—CYP3A7—endocrine gland—stomach cancer	0.000852	0.016	CbGeAlD
Nateglinide—PPARG—epithelium—stomach cancer	0.000801	0.0151	CbGeAlD
Nateglinide—ABCC4—hematopoietic system—stomach cancer	0.000796	0.015	CbGeAlD
Nateglinide—PPARG—smooth muscle tissue—stomach cancer	0.000772	0.0145	CbGeAlD
Nateglinide—CYP3A7—liver—stomach cancer	0.000768	0.0144	CbGeAlD
Nateglinide—SLC15A1—digestive system—stomach cancer	0.000764	0.0144	CbGeAlD
Nateglinide—SLC16A1—digestive system—stomach cancer	0.000727	0.0137	CbGeAlD
Nateglinide—KCNJ11—endocrine gland—stomach cancer	0.000717	0.0135	CbGeAlD
Nateglinide—PPARG—pancreas—stomach cancer	0.000714	0.0134	CbGeAlD
Nateglinide—ABCC8—endocrine gland—stomach cancer	0.00066	0.0124	CbGeAlD
Nateglinide—CYP3A7-CYP3A51P—liver—stomach cancer	0.000653	0.0123	CbGeAlD
Nateglinide—ABCC4—pancreas—stomach cancer	0.000648	0.0122	CbGeAlD
Nateglinide—SLC15A1—endocrine gland—stomach cancer	0.000631	0.0119	CbGeAlD
Nateglinide—Cough—Mitomycin—stomach cancer	0.000625	0.0138	CcSEcCtD
Nateglinide—PPARG—lymphoid tissue—stomach cancer	0.000617	0.0116	CbGeAlD
Nateglinide—PPARG—digestive system—stomach cancer	0.00061	0.0115	CbGeAlD
Nateglinide—Gastrointestinal pain—Floxuridine—stomach cancer	0.000609	0.0135	CcSEcCtD
Nateglinide—ORM1—bone marrow—stomach cancer	0.000601	0.0113	CbGeAlD
Nateglinide—SLC16A1—endocrine gland—stomach cancer	0.0006	0.0113	CbGeAlD
Nateglinide—Abdominal pain—Floxuridine—stomach cancer	0.000589	0.013	CcSEcCtD
Nateglinide—SLC15A1—liver—stomach cancer	0.000569	0.0107	CbGeAlD
Nateglinide—Injury—Irinotecan—stomach cancer	0.000562	0.0124	CcSEcCtD
Nateglinide—PPARG—bone marrow—stomach cancer	0.000562	0.0106	CbGeAlD
Nateglinide—ABCC4—digestive system—stomach cancer	0.000554	0.0104	CbGeAlD
Nateglinide—Hypersensitivity—Floxuridine—stomach cancer	0.000549	0.0121	CcSEcCtD
Nateglinide—SLC16A1—liver—stomach cancer	0.000541	0.0102	CbGeAlD
Nateglinide—ORM1—endocrine gland—stomach cancer	0.000539	0.0101	CbGeAlD
Nateglinide—Asthenia—Floxuridine—stomach cancer	0.000535	0.0118	CcSEcCtD
Nateglinide—CYP3A5—hematopoietic system—stomach cancer	0.000522	0.00981	CbGeAlD
Nateglinide—Osteoarthritis—Irinotecan—stomach cancer	0.000517	0.0114	CcSEcCtD
Nateglinide—CYP2C9—hematopoietic system—stomach cancer	0.000513	0.00966	CbGeAlD
Nateglinide—ABCC4—bone marrow—stomach cancer	0.00051	0.0096	CbGeAlD
Nateglinide—Diarrhoea—Floxuridine—stomach cancer	0.00051	0.0113	CcSEcCtD
Nateglinide—Fatigue—Mitomycin—stomach cancer	0.000504	0.0111	CcSEcCtD
Nateglinide—PPARG—endocrine gland—stomach cancer	0.000504	0.00948	CbGeAlD
Nateglinide—Lacosamide—CA1—stomach cancer	0.000499	0.123	CrCbGaD
Nateglinide—KCNJ11—lymph node—stomach cancer	0.000495	0.00932	CbGeAlD
Nateglinide—Osteoarthritis—Fluorouracil—stomach cancer	0.000495	0.0109	CcSEcCtD
Nateglinide—Spirapril—ACE—stomach cancer	0.000487	0.12	CrCbGaD
Nateglinide—ORM1—liver—stomach cancer	0.000486	0.00914	CbGeAlD
Nateglinide—Vomiting—Floxuridine—stomach cancer	0.000474	0.0105	CcSEcCtD
Nateglinide—Rash—Floxuridine—stomach cancer	0.00047	0.0104	CcSEcCtD
Nateglinide—Dermatitis—Floxuridine—stomach cancer	0.000469	0.0104	CcSEcCtD
Nateglinide—PTGS1—hematopoietic system—stomach cancer	0.000469	0.00882	CbGeAlD
Nateglinide—Mitiglinide—PPARG—stomach cancer	0.000465	0.114	CrCbGaD
Nateglinide—ABCC4—endocrine gland—stomach cancer	0.000457	0.00861	CbGeAlD
Nateglinide—PPARG—liver—stomach cancer	0.000454	0.00855	CbGeAlD
Nateglinide—Nausea—Floxuridine—stomach cancer	0.000443	0.00978	CcSEcCtD
Nateglinide—Sweating increased—Irinotecan—stomach cancer	0.000435	0.00961	CcSEcCtD
Nateglinide—Cilazapril—ACE—stomach cancer	0.000434	0.107	CrCbGaD
Nateglinide—Lisinopril—ACE—stomach cancer	0.000434	0.107	CrCbGaD
Nateglinide—Urine output increased—Capecitabine—stomach cancer	0.000431	0.00951	CcSEcCtD
Nateglinide—PTGS1—epithelium—stomach cancer	0.000428	0.00806	CbGeAlD
Nateglinide—ALB—liver—stomach cancer	0.000426	0.00802	CbGeAlD
Nateglinide—CYP3A5—pancreas—stomach cancer	0.000425	0.00799	CbGeAlD
Nateglinide—Ramipril—ACE—stomach cancer	0.000421	0.103	CrCbGaD
Nateglinide—Trandolapril—ACE—stomach cancer	0.000421	0.103	CrCbGaD
Nateglinide—Asthenia—Mitomycin—stomach cancer	0.00042	0.00927	CcSEcCtD
Nateglinide—SLC16A1—lymph node—stomach cancer	0.000415	0.00781	CbGeAlD
Nateglinide—Upper respiratory tract infection—Irinotecan—stomach cancer	0.000415	0.00917	CcSEcCtD
Nateglinide—PTGS1—smooth muscle tissue—stomach cancer	0.000413	0.00777	CbGeAlD
Nateglinide—ABCC4—liver—stomach cancer	0.000412	0.00776	CbGeAlD
Nateglinide—Diarrhoea—Mitomycin—stomach cancer	0.0004	0.00884	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.000397	0.00878	CcSEcCtD
Nateglinide—SLC15A2—endocrine gland—stomach cancer	0.000394	0.00742	CbGeAlD
Nateglinide—Polyuria—Capecitabine—stomach cancer	0.000394	0.0087	CcSEcCtD
Nateglinide—CYP3A4—hematopoietic system—stomach cancer	0.000392	0.00737	CbGeAlD
Nateglinide—Jaundice—Irinotecan—stomach cancer	0.000388	0.00857	CcSEcCtD
Nateglinide—Dizziness—Mitomycin—stomach cancer	0.000387	0.00854	CcSEcCtD
Nateglinide—CYP2D6—hematopoietic system—stomach cancer	0.000385	0.00725	CbGeAlD
Nateglinide—Sweating—Irinotecan—stomach cancer	0.000382	0.00843	CcSEcCtD
Nateglinide—Lacosamide—CA2—stomach cancer	0.000379	0.093	CrCbGaD
Nateglinide—Hepatic enzyme increased—Methotrexate—stomach cancer	0.000375	0.00828	CcSEcCtD
Nateglinide—Neuropathy peripheral—Fluorouracil—stomach cancer	0.000374	0.00826	CcSEcCtD
Nateglinide—ORM1—lymph node—stomach cancer	0.000373	0.00701	CbGeAlD
Nateglinide—Vomiting—Mitomycin—stomach cancer	0.000372	0.00821	CcSEcCtD
Nateglinide—Rash—Mitomycin—stomach cancer	0.000369	0.00814	CcSEcCtD
Nateglinide—Dermatitis—Mitomycin—stomach cancer	0.000368	0.00814	CcSEcCtD
Nateglinide—Increased appetite—Capecitabine—stomach cancer	0.000368	0.00813	CcSEcCtD
Nateglinide—Arthropathy—Epirubicin—stomach cancer	0.000365	0.00806	CcSEcCtD
Nateglinide—Thirst—Capecitabine—stomach cancer	0.000363	0.00803	CcSEcCtD
Nateglinide—CYP3A5—digestive system—stomach cancer	0.000363	0.00683	CbGeAlD
Nateglinide—CYP2C9—digestive system—stomach cancer	0.000357	0.00672	CbGeAlD
Nateglinide—PPARG—lymph node—stomach cancer	0.000348	0.00655	CbGeAlD
Nateglinide—Nausea—Mitomycin—stomach cancer	0.000347	0.00767	CcSEcCtD
Nateglinide—Osteoarthritis—Capecitabine—stomach cancer	0.000346	0.00764	CcSEcCtD
Nateglinide—Arthropathy—Doxorubicin—stomach cancer	0.000338	0.00746	CcSEcCtD
Nateglinide—ALB—lymph node—stomach cancer	0.000327	0.00615	CbGeAlD
Nateglinide—PTGS1—digestive system—stomach cancer	0.000326	0.00613	CbGeAlD
Nateglinide—Immune system disorder—Irinotecan—stomach cancer	0.000323	0.00713	CcSEcCtD
Nateglinide—Urine output increased—Methotrexate—stomach cancer	0.000321	0.00708	CcSEcCtD
Nateglinide—Enalapril—ACE—stomach cancer	0.000319	0.0783	CrCbGaD
Nateglinide—ABCC4—lymph node—stomach cancer	0.000316	0.00595	CbGeAlD
Nateglinide—Back pain—Irinotecan—stomach cancer	0.000301	0.00665	CcSEcCtD
Nateglinide—CYP3A5—endocrine gland—stomach cancer	0.0003	0.00564	CbGeAlD
Nateglinide—Influenza—Capecitabine—stomach cancer	0.000299	0.0066	CcSEcCtD
Nateglinide—CYP2C9—endocrine gland—stomach cancer	0.000295	0.00555	CbGeAlD
Nateglinide—Polyuria—Methotrexate—stomach cancer	0.000293	0.00648	CcSEcCtD
Nateglinide—Sweating increased—Capecitabine—stomach cancer	0.000291	0.00643	CcSEcCtD
Nateglinide—Bronchitis—Capecitabine—stomach cancer	0.000287	0.00635	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000278	0.00614	CcSEcCtD
Nateglinide—SLC15A2—lymph node—stomach cancer	0.000273	0.00513	CbGeAlD
Nateglinide—CYP3A4—digestive system—stomach cancer	0.000272	0.00512	CbGeAlD
Nateglinide—Cough—Irinotecan—stomach cancer	0.000272	0.006	CcSEcCtD
Nateglinide—CYP3A5—liver—stomach cancer	0.00027	0.00508	CbGeAlD
Nateglinide—Neuropathy peripheral—Docetaxel—stomach cancer	0.00027	0.00596	CcSEcCtD
Nateglinide—PTGS1—endocrine gland—stomach cancer	0.000269	0.00507	CbGeAlD
Nateglinide—Jaundice—Docetaxel—stomach cancer	0.000268	0.00593	CcSEcCtD
Nateglinide—CYP2D6—digestive system—stomach cancer	0.000268	0.00504	CbGeAlD
Nateglinide—CYP2C9—liver—stomach cancer	0.000266	0.005	CbGeAlD
Nateglinide—Neuropathy peripheral—Capecitabine—stomach cancer	0.000261	0.00577	CcSEcCtD
Nateglinide—Hepatobiliary disease—Docetaxel—stomach cancer	0.00026	0.00575	CcSEcCtD
Nateglinide—Jaundice—Capecitabine—stomach cancer	0.00026	0.00574	CcSEcCtD
Nateglinide—Osteoarthritis—Methotrexate—stomach cancer	0.000257	0.00569	CcSEcCtD
Nateglinide—Increased appetite—Epirubicin—stomach cancer	0.000256	0.00566	CcSEcCtD
Nateglinide—Hepatobiliary disease—Capecitabine—stomach cancer	0.000252	0.00557	CcSEcCtD
Nateglinide—Hypoglycaemia—Epirubicin—stomach cancer	0.000247	0.00545	CcSEcCtD
Nateglinide—Hyperhidrosis—Irinotecan—stomach cancer	0.000245	0.00542	CcSEcCtD
Nateglinide—Oedema peripheral—Docetaxel—stomach cancer	0.000243	0.00538	CcSEcCtD
Nateglinide—Osteoarthritis—Epirubicin—stomach cancer	0.000241	0.00532	CcSEcCtD
Nateglinide—Increased appetite—Doxorubicin—stomach cancer	0.000237	0.00524	CcSEcCtD
Nateglinide—Oedema peripheral—Capecitabine—stomach cancer	0.000236	0.00521	CcSEcCtD
Nateglinide—Erythema multiforme—Docetaxel—stomach cancer	0.000234	0.00516	CcSEcCtD
Nateglinide—Hypoglycaemia—Doxorubicin—stomach cancer	0.000228	0.00505	CcSEcCtD
Nateglinide—Erythema multiforme—Capecitabine—stomach cancer	0.000226	0.005	CcSEcCtD
Nateglinide—CYP3A4—endocrine gland—stomach cancer	0.000225	0.00423	CbGeAlD
Nateglinide—Dyspepsia—Irinotecan—stomach cancer	0.000224	0.00494	CcSEcCtD
Nateglinide—Immune system disorder—Docetaxel—stomach cancer	0.000223	0.00493	CcSEcCtD
Nateglinide—Osteoarthritis—Doxorubicin—stomach cancer	0.000223	0.00492	CcSEcCtD
Nateglinide—CYP2D6—endocrine gland—stomach cancer	0.000221	0.00416	CbGeAlD
Nateglinide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000219	0.00484	CcSEcCtD
Nateglinide—Fatigue—Irinotecan—stomach cancer	0.000219	0.00484	CcSEcCtD
Nateglinide—Immune system disorder—Capecitabine—stomach cancer	0.000216	0.00477	CcSEcCtD
Nateglinide—Malnutrition—Docetaxel—stomach cancer	0.000215	0.00475	CcSEcCtD
Nateglinide—Dyspepsia—Fluorouracil—stomach cancer	0.000214	0.00473	CcSEcCtD
Nateglinide—Amphetamine—CYP2A6—stomach cancer	0.000213	0.0522	CrCbGaD
Nateglinide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00021	0.00464	CcSEcCtD
Nateglinide—Malnutrition—Capecitabine—stomach cancer	0.000208	0.0046	CcSEcCtD
Nateglinide—Influenza—Epirubicin—stomach cancer	0.000208	0.0046	CcSEcCtD
Nateglinide—Back pain—Docetaxel—stomach cancer	0.000208	0.0046	CcSEcCtD
Nateglinide—Gastrointestinal pain—Irinotecan—stomach cancer	0.000208	0.00459	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000207	0.00457	CcSEcCtD
Nateglinide—CYP3A4—liver—stomach cancer	0.000203	0.00382	CbGeAlD
Nateglinide—Back pain—Capecitabine—stomach cancer	0.000201	0.00445	CcSEcCtD
Nateglinide—Abdominal pain—Irinotecan—stomach cancer	0.000201	0.00443	CcSEcCtD
Nateglinide—Bronchitis—Epirubicin—stomach cancer	0.0002	0.00442	CcSEcCtD
Nateglinide—CYP2D6—liver—stomach cancer	0.0002	0.00376	CbGeAlD
Nateglinide—Tremor—Capecitabine—stomach cancer	0.000195	0.00431	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000194	0.00427	CcSEcCtD
Nateglinide—Urticaria—Fluorouracil—stomach cancer	0.000193	0.00427	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—stomach cancer	0.000193	0.00426	CcSEcCtD
Nateglinide—Sweating—Methotrexate—stomach cancer	0.00019	0.0042	CcSEcCtD
Nateglinide—Palpitations—Docetaxel—stomach cancer	0.00019	0.0042	CcSEcCtD
Nateglinide—Cough—Docetaxel—stomach cancer	0.000188	0.00415	CcSEcCtD
Nateglinide—Hepatobiliary disease—Methotrexate—stomach cancer	0.000188	0.00414	CcSEcCtD
Nateglinide—Hypersensitivity—Irinotecan—stomach cancer	0.000187	0.00413	CcSEcCtD
Nateglinide—PTGS1—lymph node—stomach cancer	0.000186	0.0035	CbGeAlD
Nateglinide—Bronchitis—Doxorubicin—stomach cancer	0.000185	0.00409	CcSEcCtD
Nateglinide—Palpitations—Capecitabine—stomach cancer	0.000184	0.00406	CcSEcCtD
Nateglinide—Asthenia—Irinotecan—stomach cancer	0.000182	0.00402	CcSEcCtD
Nateglinide—Neuropathy peripheral—Epirubicin—stomach cancer	0.000182	0.00402	CcSEcCtD
Nateglinide—Cough—Capecitabine—stomach cancer	0.000182	0.00401	CcSEcCtD
Nateglinide—Jaundice—Epirubicin—stomach cancer	0.000181	0.004	CcSEcCtD
Nateglinide—Hypersensitivity—Fluorouracil—stomach cancer	0.000179	0.00396	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000179	0.00396	CcSEcCtD
Nateglinide—Sweating—Epirubicin—stomach cancer	0.000178	0.00393	CcSEcCtD
Nateglinide—Hepatobiliary disease—Epirubicin—stomach cancer	0.000176	0.00388	CcSEcCtD
Nateglinide—Diarrhoea—Irinotecan—stomach cancer	0.000174	0.00384	CcSEcCtD
Nateglinide—Pruritus—Fluorouracil—stomach cancer	0.000172	0.0038	CcSEcCtD
Nateglinide—Erythema multiforme—Methotrexate—stomach cancer	0.000168	0.00372	CcSEcCtD
Nateglinide—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000168	0.00372	CcSEcCtD
Nateglinide—Dizziness—Irinotecan—stomach cancer	0.000168	0.00371	CcSEcCtD
Nateglinide—Jaundice—Doxorubicin—stomach cancer	0.000167	0.0037	CcSEcCtD
Nateglinide—Diarrhoea—Fluorouracil—stomach cancer	0.000166	0.00368	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—stomach cancer	0.000165	0.00364	CcSEcCtD
Nateglinide—Hyperhidrosis—Capecitabine—stomach cancer	0.000164	0.00363	CcSEcCtD
Nateglinide—Oedema peripheral—Epirubicin—stomach cancer	0.000164	0.00363	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000162	0.00359	CcSEcCtD
Nateglinide—Vomiting—Irinotecan—stomach cancer	0.000161	0.00357	CcSEcCtD
Nateglinide—Immune system disorder—Methotrexate—stomach cancer	0.000161	0.00355	CcSEcCtD
Nateglinide—Dizziness—Fluorouracil—stomach cancer	0.000161	0.00355	CcSEcCtD
Nateglinide—Rash—Irinotecan—stomach cancer	0.00016	0.00354	CcSEcCtD
Nateglinide—Dermatitis—Irinotecan—stomach cancer	0.00016	0.00353	CcSEcCtD
Nateglinide—Erythema multiforme—Epirubicin—stomach cancer	0.000158	0.00348	CcSEcCtD
Nateglinide—Malnutrition—Methotrexate—stomach cancer	0.000155	0.00342	CcSEcCtD
Nateglinide—Vomiting—Fluorouracil—stomach cancer	0.000155	0.00342	CcSEcCtD
Nateglinide—Dyspepsia—Docetaxel—stomach cancer	0.000155	0.00341	CcSEcCtD
Nateglinide—Rash—Fluorouracil—stomach cancer	0.000153	0.00339	CcSEcCtD
Nateglinide—Dermatitis—Fluorouracil—stomach cancer	0.000153	0.00338	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—stomach cancer	0.000152	0.00336	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000152	0.00335	CcSEcCtD
Nateglinide—Fatigue—Docetaxel—stomach cancer	0.000151	0.00334	CcSEcCtD
Nateglinide—Nausea—Irinotecan—stomach cancer	0.000151	0.00333	CcSEcCtD
Nateglinide—Immune system disorder—Epirubicin—stomach cancer	0.000151	0.00333	CcSEcCtD
Nateglinide—Back pain—Methotrexate—stomach cancer	0.00015	0.00331	CcSEcCtD
Nateglinide—Dyspepsia—Capecitabine—stomach cancer	0.00015	0.0033	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000147	0.00324	CcSEcCtD
Nateglinide—Fatigue—Capecitabine—stomach cancer	0.000147	0.00324	CcSEcCtD
Nateglinide—Erythema multiforme—Doxorubicin—stomach cancer	0.000146	0.00322	CcSEcCtD
Nateglinide—Malnutrition—Epirubicin—stomach cancer	0.000145	0.0032	CcSEcCtD
Nateglinide—Nausea—Fluorouracil—stomach cancer	0.000144	0.00319	CcSEcCtD
Nateglinide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000144	0.00317	CcSEcCtD
Nateglinide—Back pain—Epirubicin—stomach cancer	0.00014	0.0031	CcSEcCtD
Nateglinide—Immune system disorder—Doxorubicin—stomach cancer	0.000139	0.00308	CcSEcCtD
Nateglinide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000139	0.00307	CcSEcCtD
Nateglinide—Abdominal pain—Docetaxel—stomach cancer	0.000139	0.00307	CcSEcCtD
Nateglinide—Cough—Methotrexate—stomach cancer	0.000135	0.00299	CcSEcCtD
Nateglinide—Urticaria—Capecitabine—stomach cancer	0.000135	0.00298	CcSEcCtD
Nateglinide—Abdominal pain—Capecitabine—stomach cancer	0.000134	0.00297	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—stomach cancer	0.000134	0.00297	CcSEcCtD
Nateglinide—Back pain—Doxorubicin—stomach cancer	0.00013	0.00287	CcSEcCtD
Nateglinide—Hypersensitivity—Docetaxel—stomach cancer	0.000129	0.00286	CcSEcCtD
Nateglinide—Palpitations—Epirubicin—stomach cancer	0.000128	0.00283	CcSEcCtD
Nateglinide—Cough—Epirubicin—stomach cancer	0.000127	0.0028	CcSEcCtD
Nateglinide—Asthenia—Docetaxel—stomach cancer	0.000126	0.00278	CcSEcCtD
Nateglinide—Hypersensitivity—Capecitabine—stomach cancer	0.000125	0.00277	CcSEcCtD
Nateglinide—Pruritus—Docetaxel—stomach cancer	0.000124	0.00274	CcSEcCtD
Nateglinide—Hyperhidrosis—Methotrexate—stomach cancer	0.000122	0.0027	CcSEcCtD
Nateglinide—Asthenia—Capecitabine—stomach cancer	0.000122	0.00269	CcSEcCtD
Nateglinide—Pruritus—Capecitabine—stomach cancer	0.00012	0.00266	CcSEcCtD
Nateglinide—Diarrhoea—Docetaxel—stomach cancer	0.00012	0.00265	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—stomach cancer	0.000119	0.00262	CcSEcCtD
Nateglinide—Cough—Doxorubicin—stomach cancer	0.000117	0.00259	CcSEcCtD
Nateglinide—Diarrhoea—Capecitabine—stomach cancer	0.000116	0.00257	CcSEcCtD
Nateglinide—Dizziness—Docetaxel—stomach cancer	0.000116	0.00256	CcSEcCtD
Nateglinide—Hyperhidrosis—Epirubicin—stomach cancer	0.000114	0.00253	CcSEcCtD
Nateglinide—Dizziness—Capecitabine—stomach cancer	0.000112	0.00248	CcSEcCtD
Nateglinide—Vomiting—Docetaxel—stomach cancer	0.000112	0.00247	CcSEcCtD
Nateglinide—Dyspepsia—Methotrexate—stomach cancer	0.000111	0.00246	CcSEcCtD
Nateglinide—Rash—Docetaxel—stomach cancer	0.000111	0.00244	CcSEcCtD
Nateglinide—Dermatitis—Docetaxel—stomach cancer	0.000111	0.00244	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000109	0.00241	CcSEcCtD
Nateglinide—Fatigue—Methotrexate—stomach cancer	0.000109	0.00241	CcSEcCtD
Nateglinide—Vomiting—Capecitabine—stomach cancer	0.000108	0.00239	CcSEcCtD
Nateglinide—Rash—Capecitabine—stomach cancer	0.000107	0.00237	CcSEcCtD
Nateglinide—Dermatitis—Capecitabine—stomach cancer	0.000107	0.00236	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—stomach cancer	0.000106	0.00234	CcSEcCtD
Nateglinide—Nausea—Docetaxel—stomach cancer	0.000104	0.0023	CcSEcCtD
Nateglinide—Dyspepsia—Epirubicin—stomach cancer	0.000104	0.0023	CcSEcCtD
Nateglinide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000103	0.00229	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000102	0.00226	CcSEcCtD
Nateglinide—Fatigue—Epirubicin—stomach cancer	0.000102	0.00225	CcSEcCtD
Nateglinide—Nausea—Capecitabine—stomach cancer	0.000101	0.00223	CcSEcCtD
Nateglinide—Urticaria—Methotrexate—stomach cancer	0.000101	0.00222	CcSEcCtD
Nateglinide—Abdominal pain—Methotrexate—stomach cancer	0.0001	0.00221	CcSEcCtD
Nateglinide—Gastrointestinal pain—Epirubicin—stomach cancer	9.68e-05	0.00214	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—stomach cancer	9.64e-05	0.00213	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.46e-05	0.00209	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—stomach cancer	9.44e-05	0.00209	CcSEcCtD
Nateglinide—Urticaria—Epirubicin—stomach cancer	9.41e-05	0.00208	CcSEcCtD
Nateglinide—Abdominal pain—Epirubicin—stomach cancer	9.36e-05	0.00207	CcSEcCtD
Nateglinide—Hypersensitivity—Methotrexate—stomach cancer	9.32e-05	0.00206	CcSEcCtD
Nateglinide—Asthenia—Methotrexate—stomach cancer	9.08e-05	0.00201	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—stomach cancer	8.96e-05	0.00198	CcSEcCtD
Nateglinide—Pruritus—Methotrexate—stomach cancer	8.95e-05	0.00198	CcSEcCtD
Nateglinide—Hypersensitivity—Epirubicin—stomach cancer	8.72e-05	0.00193	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—stomach cancer	8.7e-05	0.00192	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—stomach cancer	8.66e-05	0.00191	CcSEcCtD
Nateglinide—Diarrhoea—Methotrexate—stomach cancer	8.66e-05	0.00191	CcSEcCtD
Nateglinide—Asthenia—Epirubicin—stomach cancer	8.49e-05	0.00188	CcSEcCtD
Nateglinide—Pruritus—Epirubicin—stomach cancer	8.38e-05	0.00185	CcSEcCtD
Nateglinide—Dizziness—Methotrexate—stomach cancer	8.37e-05	0.00185	CcSEcCtD
Nateglinide—Diarrhoea—Epirubicin—stomach cancer	8.1e-05	0.00179	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—stomach cancer	8.07e-05	0.00178	CcSEcCtD
Nateglinide—Vomiting—Methotrexate—stomach cancer	8.04e-05	0.00178	CcSEcCtD
Nateglinide—Rash—Methotrexate—stomach cancer	7.98e-05	0.00176	CcSEcCtD
Nateglinide—Dermatitis—Methotrexate—stomach cancer	7.97e-05	0.00176	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—stomach cancer	7.86e-05	0.00174	CcSEcCtD
Nateglinide—Dizziness—Epirubicin—stomach cancer	7.83e-05	0.00173	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—stomach cancer	7.75e-05	0.00171	CcSEcCtD
Nateglinide—Vomiting—Epirubicin—stomach cancer	7.53e-05	0.00166	CcSEcCtD
Nateglinide—Nausea—Methotrexate—stomach cancer	7.51e-05	0.00166	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—stomach cancer	7.5e-05	0.00166	CcSEcCtD
Nateglinide—Rash—Epirubicin—stomach cancer	7.47e-05	0.00165	CcSEcCtD
Nateglinide—Dermatitis—Epirubicin—stomach cancer	7.46e-05	0.00165	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—stomach cancer	7.24e-05	0.0016	CcSEcCtD
Nateglinide—Nausea—Epirubicin—stomach cancer	7.03e-05	0.00155	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—stomach cancer	6.97e-05	0.00154	CcSEcCtD
Nateglinide—Rash—Doxorubicin—stomach cancer	6.91e-05	0.00153	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—stomach cancer	6.9e-05	0.00152	CcSEcCtD
Nateglinide—Nausea—Doxorubicin—stomach cancer	6.51e-05	0.00144	CcSEcCtD
Nateglinide—CYP2D6—Metabolism—UMPS—stomach cancer	9.41e-06	0.000118	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—KRAS—stomach cancer	9.39e-06	0.000118	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—UMPS—stomach cancer	9.33e-06	0.000117	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SREBF2—stomach cancer	9.33e-06	0.000117	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CD44—stomach cancer	9.32e-06	0.000117	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALOX5—stomach cancer	9.32e-06	0.000117	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ERCC2—stomach cancer	9.3e-06	0.000117	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTP1—stomach cancer	9.25e-06	0.000116	CbGpPWpGaD
Nateglinide—ALB—Metabolism—RORA—stomach cancer	9.22e-06	0.000116	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—DPYD—stomach cancer	9.17e-06	0.000115	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PLAU—stomach cancer	9.16e-06	0.000115	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—KRAS—stomach cancer	9.15e-06	0.000115	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—HMOX1—stomach cancer	9.12e-06	0.000115	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CD44—stomach cancer	9.04e-06	0.000114	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—CAV1—stomach cancer	8.94e-06	0.000112	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	8.94e-06	0.000112	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—APOA1—stomach cancer	8.92e-06	0.000112	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ALB—stomach cancer	8.89e-06	0.000112	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PGLS—stomach cancer	8.87e-06	0.000112	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BLVRB—stomach cancer	8.87e-06	0.000112	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.77e-06	0.00011	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ECHS1—stomach cancer	8.75e-06	0.00011	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PDHA1—stomach cancer	8.75e-06	0.00011	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—MTHFR—stomach cancer	8.74e-06	0.00011	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PDHA1—stomach cancer	8.67e-06	0.000109	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ECHS1—stomach cancer	8.67e-06	0.000109	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ALDOB—stomach cancer	8.64e-06	0.000109	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ALB—stomach cancer	8.62e-06	0.000108	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TYMS—stomach cancer	8.6e-06	0.000108	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PRKCB—stomach cancer	8.51e-06	0.000107	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	8.51e-06	0.000107	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—NOS3—stomach cancer	8.5e-06	0.000107	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTM1—stomach cancer	8.5e-06	0.000107	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ALB—stomach cancer	8.5e-06	0.000107	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPAP2A—stomach cancer	8.47e-06	0.000106	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PIK3CA—stomach cancer	8.41e-06	0.000106	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—NOS3—stomach cancer	8.25e-06	0.000104	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—FADS1—stomach cancer	8.22e-06	0.000103	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TYMP—stomach cancer	8.22e-06	0.000103	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SERPINE1—stomach cancer	8.21e-06	0.000103	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—FADS1—stomach cancer	8.15e-06	0.000102	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TYMP—stomach cancer	8.15e-06	0.000102	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.14e-06	0.000102	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—stomach cancer	8.14e-06	0.000102	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—NOS3—stomach cancer	8.13e-06	0.000102	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.12e-06	0.000102	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTT1—stomach cancer	8.11e-06	0.000102	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CAV1—stomach cancer	8.06e-06	0.000101	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—APOA1—stomach cancer	8.04e-06	0.000101	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ALOX5—stomach cancer	8.03e-06	0.000101	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP2A6—stomach cancer	8.02e-06	0.000101	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ERCC2—stomach cancer	7.99e-06	0.0001	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—stomach cancer	7.98e-06	0.0001	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPP2R1A—stomach cancer	7.93e-06	9.96e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—DPYD—stomach cancer	7.9e-06	9.93e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKR1C3—stomach cancer	7.8e-06	9.8e-05	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HRAS—stomach cancer	7.78e-06	9.78e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—stomach cancer	7.78e-06	9.78e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTP1—stomach cancer	7.78e-06	9.77e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	7.73e-06	9.71e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.7e-06	9.68e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SREBF2—stomach cancer	7.7e-06	9.68e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPP2R1A—stomach cancer	7.68e-06	9.66e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—HMOX1—stomach cancer	7.67e-06	9.64e-05	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—IL6—stomach cancer	7.64e-06	9.6e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SREBF2—stomach cancer	7.63e-06	9.59e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—RORA—stomach cancer	7.61e-06	9.56e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ENO1—stomach cancer	7.6e-06	9.55e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NDUFA2—stomach cancer	7.55e-06	9.48e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—FBP1—stomach cancer	7.55e-06	9.48e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CKB—stomach cancer	7.55e-06	9.48e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CA1—stomach cancer	7.55e-06	9.48e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—RORA—stomach cancer	7.54e-06	9.48e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—stomach cancer	7.54e-06	9.48e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTP1—stomach cancer	7.54e-06	9.47e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—MTHFR—stomach cancer	7.51e-06	9.44e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—stomach cancer	7.43e-06	9.34e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—HMOX1—stomach cancer	7.43e-06	9.34e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	7.38e-06	9.28e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TYMS—stomach cancer	7.23e-06	9.09e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.16e-06	9e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTM1—stomach cancer	7.15e-06	8.98e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALDOB—stomach cancer	7.13e-06	8.96e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLIN2—stomach cancer	7.09e-06	8.92e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SERPINE1—stomach cancer	7.08e-06	8.9e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALDOB—stomach cancer	7.07e-06	8.88e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TYMS—stomach cancer	7.01e-06	8.81e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTT1—stomach cancer	6.98e-06	8.78e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CAV1—stomach cancer	6.93e-06	8.71e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTM1—stomach cancer	6.93e-06	8.71e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—APOA1—stomach cancer	6.91e-06	8.69e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2A6—stomach cancer	6.9e-06	8.68e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CA2—stomach cancer	6.9e-06	8.67e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—RHOA—stomach cancer	6.83e-06	8.59e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NOS3—stomach cancer	6.76e-06	8.5e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CD44—stomach cancer	6.74e-06	8.47e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NT5E—stomach cancer	6.73e-06	8.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PGAM1—stomach cancer	6.73e-06	8.45e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ERCC2—stomach cancer	6.72e-06	8.44e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKR1C3—stomach cancer	6.72e-06	8.44e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.67e-06	8.38e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.65e-06	8.36e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALOX5—stomach cancer	6.63e-06	8.33e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.62e-06	8.32e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALOX5—stomach cancer	6.57e-06	8.26e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ENO1—stomach cancer	6.54e-06	8.23e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—DPYD—stomach cancer	6.52e-06	8.2e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ERCC2—stomach cancer	6.51e-06	8.19e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—DPYD—stomach cancer	6.46e-06	8.13e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	6.42e-06	8.06e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLCE1—stomach cancer	6.42e-06	8.06e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—stomach cancer	6.37e-06	8.01e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—MTHFR—stomach cancer	6.32e-06	7.94e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—UMPS—stomach cancer	6.15e-06	7.73e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—MTHFR—stomach cancer	6.12e-06	7.69e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NOS3—stomach cancer	6.09e-06	7.66e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARG—stomach cancer	6.09e-06	7.65e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.86e-06	7.36e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CAV1—stomach cancer	5.83e-06	7.32e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOA1—stomach cancer	5.81e-06	7.31e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CD44—stomach cancer	5.8e-06	7.3e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTT1—stomach cancer	5.77e-06	7.25e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPP2R1A—stomach cancer	5.73e-06	7.2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PDHA1—stomach cancer	5.72e-06	7.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ECHS1—stomach cancer	5.72e-06	7.19e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTT1—stomach cancer	5.72e-06	7.19e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2A6—stomach cancer	5.7e-06	7.16e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2A6—stomach cancer	5.65e-06	7.1e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CAV1—stomach cancer	5.65e-06	7.1e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOA1—stomach cancer	5.63e-06	7.08e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.63e-06	7.08e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—stomach cancer	5.62e-06	7.07e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—stomach cancer	5.57e-06	7.01e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKR1C3—stomach cancer	5.54e-06	6.97e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMOX1—stomach cancer	5.54e-06	6.97e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKR1C3—stomach cancer	5.5e-06	6.91e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—stomach cancer	5.48e-06	6.88e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ENO1—stomach cancer	5.4e-06	6.79e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.39e-06	6.78e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TYMP—stomach cancer	5.38e-06	6.76e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—FADS1—stomach cancer	5.38e-06	6.76e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ENO1—stomach cancer	5.36e-06	6.73e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MAPK3—stomach cancer	5.34e-06	6.71e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.27e-06	6.62e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NOS3—stomach cancer	5.24e-06	6.58e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TYMS—stomach cancer	5.23e-06	6.57e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—stomach cancer	5.2e-06	6.53e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—stomach cancer	5.17e-06	6.49e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—stomach cancer	5.12e-06	6.44e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SREBF2—stomach cancer	5.03e-06	6.33e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—RORA—stomach cancer	4.97e-06	6.25e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—stomach cancer	4.96e-06	6.24e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPP2R1A—stomach cancer	4.94e-06	6.2e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—stomach cancer	4.87e-06	6.12e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ERCC2—stomach cancer	4.86e-06	6.1e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—stomach cancer	4.84e-06	6.08e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CD44—stomach cancer	4.79e-06	6.02e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—stomach cancer	4.79e-06	6.02e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—stomach cancer	4.79e-06	6.01e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMOX1—stomach cancer	4.77e-06	6e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CD44—stomach cancer	4.75e-06	5.97e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDOB—stomach cancer	4.66e-06	5.86e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—stomach cancer	4.64e-06	5.83e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.61e-06	5.79e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK3—stomach cancer	4.61e-06	5.79e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—stomach cancer	4.6e-06	5.79e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—stomach cancer	4.57e-06	5.75e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—stomach cancer	4.57e-06	5.74e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TYMS—stomach cancer	4.5e-06	5.66e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—stomach cancer	4.46e-06	5.61e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—stomach cancer	4.45e-06	5.59e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NOS3—stomach cancer	4.4e-06	5.54e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK1—stomach cancer	4.39e-06	5.51e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALOX5—stomach cancer	4.33e-06	5.45e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NOS3—stomach cancer	4.27e-06	5.37e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DPYD—stomach cancer	4.26e-06	5.36e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAV1—stomach cancer	4.21e-06	5.29e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOA1—stomach cancer	4.2e-06	5.28e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ERCC2—stomach cancer	4.18e-06	5.26e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—stomach cancer	4.14e-06	5.21e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.07e-06	5.12e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.04e-06	5.08e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—stomach cancer	4.03e-06	5.06e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—stomach cancer	4e-06	5.02e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—stomach cancer	3.96e-06	4.98e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMOX1—stomach cancer	3.94e-06	4.95e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—stomach cancer	3.93e-06	4.94e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMOX1—stomach cancer	3.91e-06	4.91e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—stomach cancer	3.9e-06	4.91e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—stomach cancer	3.81e-06	4.78e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTT1—stomach cancer	3.77e-06	4.74e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.73e-06	4.68e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TYMS—stomach cancer	3.72e-06	4.67e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—stomach cancer	3.7e-06	4.65e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TYMS—stomach cancer	3.68e-06	4.63e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—stomach cancer	3.68e-06	4.63e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—stomach cancer	3.67e-06	4.62e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—stomach cancer	3.64e-06	4.58e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAV1—stomach cancer	3.63e-06	4.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.63e-06	4.56e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOA1—stomach cancer	3.62e-06	4.55e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ENO1—stomach cancer	3.53e-06	4.44e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—stomach cancer	3.52e-06	4.43e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.46e-06	4.35e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ERCC2—stomach cancer	3.45e-06	4.34e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—stomach cancer	3.43e-06	4.31e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ERCC2—stomach cancer	3.42e-06	4.3e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—stomach cancer	3.33e-06	4.18e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—stomach cancer	3.25e-06	4.08e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—stomach cancer	3.22e-06	4.04e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—stomach cancer	3.19e-06	4.01e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NOS3—stomach cancer	3.18e-06	4e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CD44—stomach cancer	3.13e-06	3.94e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAV1—stomach cancer	2.99e-06	3.76e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOA1—stomach cancer	2.99e-06	3.75e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAV1—stomach cancer	2.97e-06	3.73e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOA1—stomach cancer	2.96e-06	3.72e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—stomach cancer	2.95e-06	3.7e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—stomach cancer	2.91e-06	3.66e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.84e-06	3.56e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NOS3—stomach cancer	2.74e-06	3.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.66e-06	3.35e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—stomach cancer	2.63e-06	3.31e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—stomach cancer	2.61e-06	3.28e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—stomach cancer	2.61e-06	3.28e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMOX1—stomach cancer	2.58e-06	3.24e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—stomach cancer	2.51e-06	3.15e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—stomach cancer	2.48e-06	3.12e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TYMS—stomach cancer	2.43e-06	3.05e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—stomach cancer	2.4e-06	3.02e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—stomach cancer	2.4e-06	3.02e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—stomach cancer	2.37e-06	2.97e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—stomach cancer	2.35e-06	2.95e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NOS3—stomach cancer	2.26e-06	2.85e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ERCC2—stomach cancer	2.26e-06	2.84e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NOS3—stomach cancer	2.24e-06	2.82e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—stomach cancer	2.12e-06	2.67e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—stomach cancer	2.07e-06	2.6e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—stomach cancer	2.05e-06	2.58e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAV1—stomach cancer	1.96e-06	2.46e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA1—stomach cancer	1.95e-06	2.45e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—stomach cancer	1.79e-06	2.25e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—stomach cancer	1.72e-06	2.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—stomach cancer	1.55e-06	1.95e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—stomach cancer	1.54e-06	1.94e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NOS3—stomach cancer	1.48e-06	1.86e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—stomach cancer	1.35e-06	1.7e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.27e-06	1.6e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.26e-06	1.59e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.33e-07	1.05e-05	CbGpPWpGaD
